The human genome-edited SOD1-G93A MNs, as well as MNs generated from a patient-derived iPSC line with SOD1-A4V, developed robust disease phenotypes including proteinopathy, structural attrition, axonopathy, synaptic pathology, and functional defects. This evidence concerns the gene SOD1 and proteostasis deficiencies.